Login / Signup

Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports.

Usha GurunathanShakeel Meeran KunjuLisa May Lin Stanton
Published in: BMC anesthesiology (2019)
Majority of the articles reviewed report successful use of sugammadex to reverse steroidal muscle relaxants, especially rocuronium, in patients with neuromuscular diseases. However, with sugammadex, unpredictability in response and uncertainty regarding optimum dose still remain issues. Quantitative neuromuscular monitoring to ensure complete reversal and adequate postoperative monitoring is strongly recommended in these patients, despite the use of sugammadex.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • patients undergoing
  • case report
  • high resolution
  • patient reported outcomes
  • anti inflammatory drugs